Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
| 2 |
CVS Health
CVS
|
+$189M |
| 3 |
Mastercard
MA
|
+$155M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$112M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$814M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$763M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$315M |
| 4 |
SPDR Gold Trust
GLD
|
+$140M |
| 5 |
JD.com
JD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.96% |
| 2 | Healthcare | 19.03% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cencora
COR
$61.2B
| $49.3M | 0.21% |
348,306
+99,409
| +40% | +$15.2M |
|
102
Micron Technology
MU
$991B
| $49M | 0.21% |
885,780
+326,466
| +58% | +$22.2M |
|
103
Idexx Laboratories
IDXX
$46.2B
| $48.1M | 0.2% |
137,201
-2,240
| -2% | -$913K |
|
104
DexCom
DXCM
$32B
| $47.2M | 0.2% |
633,054
+52,090
| +9% | +$4.75M |
|
105
Restaurant Brands International
QSR
$25.8B
| $46M | 0.19% |
918,036
+35,329
| +4% | +$1.89M |
|
106
Advanced Micro Devices
AMD
$789B
| $45.1M | 0.19% |
590,316
+443,214
| +301% | +$41.5M |
|
107
Hormel Foods
HRL
$13.8B
| $44.8M | 0.19% |
945,616
+72,232
| +8% | +$3.6M |
|
|
HOLX
108
DELISTED
Hologic
HOLX
| $44.3M | 0.19% |
638,634
+246,407
| +63% | +$18.3M |
|
109
IBM
IBM
$224B
| $44.2M | 0.19% |
312,891
-63,262
| -17% | -$8.54M |
|
110
Regeneron Pharmaceuticals
REGN
$80.8B
| $43.7M | 0.19% |
73,900
+68,448
| +1,255% | +$44.5M |
|
111
Darden Restaurants
DRI
$24.4B
| $43.7M | 0.19% |
386,021
+28,252
| +8% | +$3.53M |
|
112
Caterpillar
CAT
$387B
| $42.1M | 0.18% |
235,722
+60,535
| +35% | +$12.8M |
|
113
D.R. Horton
DHI
$42.3B
| $41.7M | 0.18% |
630,342
+375,138
| +147% | +$26.4M |
|
114
Clorox
CLX
$12.7B
| $41.6M | 0.18% |
295,162
-16,876
| -5% | -$2.41M |
|
115
Zimmer Biomet
ZBH
$18.4B
| $41.4M | 0.18% |
393,756
-20,154
| -5% | -$2.39M |
|
116
Labcorp
LH
$25.9B
| $41.1M | 0.17% |
204,192
+17,834
| +10% | +$3.8M |
|
117
American Homes 4 Rent
AMH
$12.5B
| $40.2M | 0.17% |
1,133,833
+842,906
| +290% | +$31.9M |
|
118
Progressive
PGR
$125B
| $39.8M | 0.17% |
342,482
+139,597
| +69% | +$15.8M |
|
119
Wells Fargo
WFC
$264B
| $39.8M | 0.17% |
1,015,924
+216,926
| +27% | +$9.52M |
|
120
Lennar Class A
LEN
$21.2B
| $39.6M | 0.17% |
580,141
+313,738
| +118% | +$23M |
|
121
SLB Ltd
SLB
$75B
| $38.9M | 0.16% |
1,086,420
+684,443
| +170% | +$28.5M |
|
122
Align Technology
ALGN
$12.3B
| $38.6M | 0.16% |
163,307
+47,669
| +41% | +$14.6M |
|
123
J.M. Smucker
SJM
$12.8B
| $38.6M | 0.16% |
301,693
+25,531
| +9% | +$3.4M |
|
124
Zillow
Z
$7.56B
| $38.6M | 0.16% |
1,215,164
+1,080,700
| +804% | +$43.4M |
|
125
GE Aerospace
GE
$384B
| $38.6M | 0.16% |
972,229
+293,438
| +43% | +$14.2M |
|
Similar funds
Ray Dalio's Q2 2022 Portfolio in Review
As of Q2 2022, Ray Dalio held 1,084 positions worth $23.6B, down 4.9% from $24.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ray Dalio deployed $1.38B of net new capital in Q2 2022, opening 116 new positions and adding to 613 existing holdings. Its largest new stake was Sea Limited: 459,240 shares worth $30.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $763M trimmed.
- Ray Dalio's largest Q2 2022 buy was Sea Limited: 459,240 shares worth $30.7M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $236M increase.
- Ray Dalio's biggest Q2 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $763M.
- Ray Dalio fully exited Alibaba in Q2 2022, selling an estimated $814M.
- Ray Dalio's ten largest holdings make up 29% of its $23.6B portfolio in Q2 2022.
- Ray Dalio opened 116 new positions and closed 99 in Q2 2022.
- Ray Dalio's portfolio value fell 4.9% quarter-over-quarter to $23.6B.
Based on Bridgewater Associates's 13F filing for Q2 2022, filed 11 Aug 2022.